Amyloidosis and Lung Cancer

Clinical systemic amyloidosis has been rarely described in patients with lung cancer. A new case of such an association is described with a review of the literature and a discussion about the possible biological mechanisms responsible for the development of systemic amyloidosis in patients with lung...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical lung cancer Vol. 4; no. 4; pp. 249 - 251
Main Authors:	Barceló, J. Ramón, Muñoz, Alberto, Mañé, Joan M., Rubio, Itziar, Pérez-Hoyos, Teresa, Viteri, Ainhoa, López-Vivanco, Guillermo M.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-01-2003
Subjects:	AA amyloid Acquired systemic amyloidosis non–small-cell lung cancer Serum AA amyloid non–small-cell lung cancer Acquired systemic amyloidosis Serum AA amyloid AA amyloid
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Clinical systemic amyloidosis has been rarely described in patients with lung cancer. A new case of such an association is described with a review of the literature and a discussion about the possible biological mechanisms responsible for the development of systemic amyloidosis in patients with lung cancer. Circulating precursors of amyloid fibrils in patients with lung cancer might be implicated more than expected in the biology of tumoral disease.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1525-7304 1938-0690
DOI:	10.3816/CLC.2003.n.006